Jensen; Klaus Gjervig

Patent Applications and Registrations

Patent applications and USPTO patent grants for Jensen; Klaus Gjervig.The latest application filed is for "new catecholamine prodrugs for use in the treatment of parkinson's disease".

Company Profile

7.12.18

Jensen; Klaus Gjervig - Valby DK
JENSEN; Klaus Gjervig - Kobenhavn K DK
Jensen; Klaus Gjervig - Copenhagen DK
Jensen; Klaus Gjervig - Copenhagen K DK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
New Catecholamine Prodrugs For Use In The Treatment Of Parkinson's Disease App 20220257623 - Jensen; Klaus Gjervig ; et al.	2022-08-18
New Catecholamine Prodrugs For Use In The Treatment Of Parkinson's Disease App 20220220077 - Jorgensen; Morten ; et al.	2022-07-14
New Catecholamine Prodrugs For Use In The Treatment Of Parkinson's Diseases App 20220213136 - Jorgensen; Morten ; et al.	2022-07-07
Catecholamine Carbamate Prodrugs For Use In The Treatment Of Parkinson's Disease App 20220213040 - Jorgensen; Morten ; et al.	2022-07-07
New Catecholamine Prodrugs For Use In The Treatment Of Parkinson's Disease App 20220213071 - Jorgensen; Morten ; et al.	2022-07-07
Deuterated 1-piperazino-3-phenyl Indanes For Treatment Of Schizophrenia App 20220119362 - JORGENSEN; Morten ; et al.	2022-04-21
Solid Forms Of (2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(((4ar,10ar)-7-hydroxy-1-propyl-1,2,3- ,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2h-pyran-2-ca- Rboxylic Acid App 20220024962 - Jensen; Klaus Gjervig ; et al.	2022-01-27
Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3- ,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-ca- rboxylic acid Grant 11,130,775 - Jensen , et al. September 28, 2	2021-09-28
Catecholamine prodrugs for use in the treatment of Parkinson's disease Grant 11,110,110 - Jensen , et al. September 7, 2	2021-09-07
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia Grant 11,059,798 - Jorgensen , et al. July 13, 2	2021-07-13
Solid Forms Of (2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(((4ar,10ar)-7-hydroxy-1-propyl-1,2,3- ,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2h-pyran-2-ca- Rboxylic Acid App 20200392176 - Jensen; Klaus Gjervig ; et al.	2020-12-17
Catecholamine Prodrugs For Use In The Treatment Of Parkinson's Disease App 20200338102 - Jensen; Klaus Gjervig ; et al.	2020-10-29
Catecholamine prodrugs for use in the treatment of Parkinson's disease Grant 10,729,710 - Jensen , et al.	2020-08-04
Deuterated 1-piperazino-3-phenyl Indanes For Treatment Of Schizophrenia App 20200131143 - JORGENSEN; Morten ; et al.	2020-04-30
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia Grant 10,501,427 - Jorgensen , et al. Dec	2019-12-10
Catecholamine Prodrugs For Use In The Treatment Of Parkinson's Disease App 20190160083 - Jensen; Klaus Gjervig ; et al.	2019-05-30
Deuterated 1-piperazino-3-phenyl Indanes For Treatment Of Schizophrenia App 20190031631 - JORGENSEN; Morten ; et al.	2019-01-31
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia Grant 10,118,907 - Jorgensen , et al. November 6, 2	2018-11-06
Deuterated 1-piperazino-3-phenyl Indanes For Treatment Of Schizophrenia App 20170158650 - JORGENSEN; Morten ; et al.	2017-06-08
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia Grant 9,617,231 - Jorgensen , et al. April 11, 2	2017-04-11
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia App 20160068497 - JORGENSEN; Morten ; et al.	2016-03-10
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia Grant 9,216,961 - Jorgensen , et al. December 22, 2	2015-12-22
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia App 20150307458 - JORGENSEN; Morten ; et al.	2015-10-29
Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia Grant 9,012,453 - Jorgensen , et al. April 21, 2	2015-04-21
Deuterated 1-piperazino-3-phenyl-indanes for treatment of schizophrenia Grant 8,575,174 - Jorgensen , et al. November 5, 2	2013-11-05
Deuterated 1-piperazino-3-phenyl Indanes For Treatment Of Schizophrenia App 20130281436 - JORGENSEN; Morten ; et al.	2013-10-24
Deuterated 1-piperazino-3-phenyl-indanes For Treatment Of Schizophrenia App 20120322811 - JORGENSEN; Morten ; et al.	2012-12-20
Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine Grant 7,772,240 - Bang-Andersen , et al. August 10, 2	2010-08-10
Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine App 20060281758 - Bang-Andersen; Benny ; et al.	2006-12-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.